SCCS Concerns over the Safety of the Use of Prostaglandin...
The SCCS has evaluated all submitted information on the three prostaglandin analogues (PGAs) – Isopropyl Cloprostenate (IPCP), 0.005%, Methylamido-Dihydro-Noralfaprostal (MDN) 0.03% and Dechloro Dihydroxy Difluoro Ethylcloprostenolamide (DDDE) 0.015%/0.018%, intended to...
